These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 23801799

  • 1. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass.
    Gerhard GS, Styer AM, Wood GC, Roesch SL, Petrick AT, Gabrielsen J, Strodel WE, Still CD, Argyropoulos G.
    Diabetes Care; 2013 Jul; 36(7):1859-64. PubMed ID: 23801799
    [Abstract] [Full Text] [Related]

  • 2. FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes.
    Sachdev S, Wang Q, Billington C, Connett J, Ahmed L, Inabnet W, Chua S, Ikramuddin S, Korner J.
    Obes Surg; 2016 May; 26(5):957-65. PubMed ID: 26259981
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute Changes of Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.
    Chen Y, Lu J, Nemati R, Plank LD, Murphy R.
    Obes Surg; 2019 Nov; 29(11):3605-3621. PubMed ID: 31273649
    [Abstract] [Full Text] [Related]

  • 5. Modulation of fibroblast growth factor 19 expression by bile acids, meal replacement and energy drinks, milk, and coffee.
    Styer AM, Roesch SL, Argyropoulos G.
    PLoS One; 2014 Nov; 9(1):e85558. PubMed ID: 24465600
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Perturbations of fibroblast growth factors 19 and 21 in type 2 diabetes.
    Roesch SL, Styer AM, Wood GC, Kosak Z, Seiler J, Benotti P, Petrick AT, Gabrielsen J, Strodel WE, Gerhard GS, Still CD, Argyropoulos G.
    PLoS One; 2015 Nov; 10(2):e0116928. PubMed ID: 25664662
    [Abstract] [Full Text] [Related]

  • 8. Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery.
    Jansen PL, van Werven J, Aarts E, Berends F, Janssen I, Stoker J, Schaap FG.
    Dig Dis; 2011 Nov; 29(1):48-51. PubMed ID: 21691104
    [Abstract] [Full Text] [Related]

  • 9. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.
    Lundåsen T, Gälman C, Angelin B, Rudling M.
    J Intern Med; 2006 Dec; 260(6):530-6. PubMed ID: 17116003
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study.
    De Giorgi S, Campos V, Egli L, Toepel U, Carrel G, Cariou B, Rainteau D, Schneiter P, Tappy L, Giusti V.
    Clin Nutr; 2015 Oct; 34(5):911-7. PubMed ID: 25306425
    [Abstract] [Full Text] [Related]

  • 11. Altered bile acid kinetics contribute to postprandial hypoglycaemia after Roux-en-Y gastric bypass surgery.
    van den Broek M, de Heide LJM, Sips FLP, Koehorst M, van Zutphen T, Emous M, van Faassen M, Groen AK, van Riel NAW, de Boer JF, van Beek AP, Kuipers F.
    Int J Obes (Lond); 2021 Mar; 45(3):619-630. PubMed ID: 33452416
    [Abstract] [Full Text] [Related]

  • 12. Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats.
    Bhutta HY, Rajpal N, White W, Freudenberg JM, Liu Y, Way J, Rajpal D, Cooper DC, Young A, Tavakkoli A, Chen L.
    PLoS One; 2015 Mar; 10(3):e0122273. PubMed ID: 25798945
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids.
    Mazidi M, de Caravatto PP, Speakman JR, Cohen RV.
    Obes Surg; 2017 Mar; 27(3):826-836. PubMed ID: 28091894
    [Abstract] [Full Text] [Related]

  • 14. Fecal bile acid profile after Roux-en-Y gastric bypass and its association with the remission of type 2 diabetes in obese women: A preliminary study.
    de Siqueira Cardinelli C, Torrinhas RS, Sala P, Pudenzi MA, Fernando F Angolini C, Marques da Silva M, Machado NM, Ravacci G, Eberlin MN, Waitzberg DL.
    Clin Nutr; 2019 Dec; 38(6):2906-2912. PubMed ID: 30799193
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.
    Lalloyer F, Mogilenko DA, Verrijken A, Haas JT, Lamazière A, Kouach M, Descat A, Caron S, Vallez E, Derudas B, Gheeraert C, Baugé E, Despres G, Dirinck E, Tailleux A, Dombrowicz D, Van Gaal L, Eeckhoute J, Lefebvre P, Goossens JF, Francque S, Staels B.
    J Hepatol; 2023 Oct; 79(4):898-909. PubMed ID: 37230231
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
    Gómez-Ambrosi J, Gallego-Escuredo JM, Catalán V, Rodríguez A, Domingo P, Moncada R, Valentí V, Salvador J, Giralt M, Villarroya F, Frühbeck G.
    Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
    [Abstract] [Full Text] [Related]

  • 19. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y, Sha Y, Huang X, Yuan W, Wu F, Hong J, Fang S, Huang B, Hu C, Wang B, Zhang X.
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.